NOV 29, 2019 6:17 AM PST

Protecting Killer Immune Cells from Themselves

WRITTEN BY: Kara Marker

Destroying human cells compromised by viruses and cancer is the name of the game for so-called “killer” cells of the immune system. They employ aggressive tactics to live up to their name, but how can they protect themselves from friendly fire? A new research study identifies the precise protective mechanism.

 

Image source: NIAID

 

“Killer” immune cells, namely natural killer (NK) cells and cytotoxic T cells, produce toxic proteins called perforins to target and destroy cancerous and virally-infected cells. Perforin is a glycoprotein that creates pores in the cell membranes of target cells; in this scenario, the target cells are those taken over by cancer or virus. Perforin is a key player in the immune system: the inflammatory response to microbial infection, immune surveillance, immunopathology, autoimmune disease, and allogeneic transplant rejection.

Researchers from the present study found that the more ordered and tightly packed the lipids were in the lipid membrane that makes up the cell surface of killer immune cells, the less perforins bound to the cell surface. When researchers manipulated this order and packing, they observed increased cellular sensitivity to perforin.

However, even when the killer immune cells were experiencing overexposure to perforin - so much so that the perforin stuck to the surface of the cells - they still remained unaffected by perforin’s usual cellular destruction effects. Researchers ultimately discovered that this was thanks to the negative charge of select lipids that were sent to the cell surface; these lipids bound the extraneous perforin and prevented any cellular destruction.

"We have long known that local lipid order can change how cells communicate which each other, but it was rather surprising that the precise physical membrane properties can also provide such an important layer of protection against molecular hole-punchers,” explained joint first author Adrian Hodel.

The study’s findings go beyond simply understanding more about the protective mechanisms employed by killer immune cells. Researchers theorize that cancer cells may mimic this protective action to evade destruction by the immune system. This could be the reason why certain types of cancer are less susceptible than others to immunotherapies, which rely on maximizing the natural power of the immune system to target cancer.

Sources: University College London, Nature Communications, Central European Journal of Immunology

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 24, 2021
Immunology
Women Produce More COVID Antibodies Than Men
AUG 24, 2021
Women Produce More COVID Antibodies Than Men
An exploration into the human immune response after a COVID-19 infection has revealed a surprising finding: women produc ...
SEP 09, 2021
Cancer
Can a Mole Fight Melanoma?
SEP 09, 2021
Can a Mole Fight Melanoma?
About 30% of melanoma cases arise from an existing nevus.  More commonly known as moles, Nevi are skin growths that ...
SEP 16, 2021
Cancer
Inspiring Hope during Childhood Cancer Awareness Month
SEP 16, 2021
Inspiring Hope during Childhood Cancer Awareness Month
Childhood cancers, also known as pediatric cancers, are diagnosed in patients up to 14 years old.  Estimates for 20 ...
SEP 21, 2021
Immunology
1 in 5 Hospitalized COVID Patients Develop Self-Destructive Antibodies
SEP 21, 2021
1 in 5 Hospitalized COVID Patients Develop Self-Destructive Antibodies
One in five hospitalized COVID-19 patients go on to develop autoantibodies—immune molecules that mistakenly target ...
SEP 24, 2021
Drug Discovery & Development
WHO Recommends Antibody Treatment for High Risk COVID-19 Patients
SEP 24, 2021
WHO Recommends Antibody Treatment for High Risk COVID-19 Patients
The World Health Organization (WHO) has recommended a combination of two antibody treatments for patients at risk of adv ...
NOV 30, 2021
Immunology
The Body Makes Its Own Anti-inflammatory 'Cannabis' After a Workout
NOV 30, 2021
The Body Makes Its Own Anti-inflammatory 'Cannabis' After a Workout
Feeling great after hitting the gym? That’s because of the flood of endorphins released into the body after a bout ...
Loading Comments...